Roche to acquire US-based Poseida Therapeutics for $1.5 billion
Switzerland’s F. Hoffmann-La Roche AG will buy US-based biopharmaceutical company Poseida Therapeutics for $1.5 billion, according to a statement from the Basel-headquartered company.
Drugs
Health
Pharma
Climate
Health
Pharma
Global warming on backburner; vexed financing deal sees light at COP29
Global representatives at a climate conference signed a $300 billion-a-year deal to finance emissions reductions — a move developing nations say falls way.
Health
Medical
Research
“Phantom chemical” in US drinking water raises health concerns
HQ Team November 23, 2024: A study has finally identified a previously unknown chemical, chloronitramide anion, lurking in drinking water across the United States,.
Drugs
Health
Pharma
Measles cases surge worldwide, access to vaccine is ‘inadequate’: WHO
Measles cases worldwide have risen 20% year-on-year in 2023 to about 10.3 million due to inadequate access to vaccines, according to new estimates.
Drugs
Health
Pharma
AstraZeneca to invest $3.5 billion in the US to expand global footprint
Britain's AstraZeneca will invest $3.5 billion in the US, its largest market, to expand its research and manufacturing footprint by the end of.
Drugs
Health
Pharma
US public health agency updates bird flu guidance for farm workers
US farm workers exposed to bird flu who do not show symptoms and do not wear personal protection equipment should be tested for.
Drugs
Health
Pharma
Novo Nordisk’s weight loss drug reduces live scarring in end-stage trial
Danish multinational pharmaceutical company Novo Nordisk’s end-stage trial in patients with fatty liver disease saw reduced liver scarring (fibrosis) and its resolution without.
Drugs
Health
Pharma
AbbVie to acquire Aliada for $1.4 billion, bags Alzheimer’s therapy
AbbVie Inc. will acquire Aliada Therapeutics, a biotechnology company focused on developing drugs to treat diseases of the central nervous system such as.
Drugs
Health
Pharma
AstraZeneca’s drug to treat rare blood vessel disease gets EU nod
AstraZeneca Plc’s drug Fasenra got approval from the European Union regulator for treating adult patients with a rare inflammation of blood vessels.
Drugs
Health
Pharma
GSK to invest $800 million in US to double capacity at Marietta facility
GSK Plc., will invest $800 million in its manufacturing facility in the US — the largest investment to date in the country — to.